Inventor · disambiguated record
Sebastien Louis Degorce
Also filed as: DEGORCE SEBASTIEN LOUIS · DEGORCE SÉBASTIEN L
7 granted patents·6 pending applications·34 citations·filing 2010–2025
83Inventor score
Files withASTRAZENECA AB8HOTSPOT THERAPEUTICS INC2BARLAAM BERNARD CHISTROPHE1BARLAAM BERNARD CHRISTOPHE1BRIDGE MEDICINES1
Top patents by PatentIndex Score
13 records- 0194US11325906B2Chemical compoundsASTRAZENECA AB·Filed 2020·Granted May 10, 2022·8 cites·2 claims
- 0292US11795158B2Chemical compoundsASTRAZENECA AB·Filed 2021·Granted Oct 24, 2023·3 cites·4 claims
- 0384US8399460B2Chromenone derivativesBARLAAM BERNARD CHISTROPHE·Filed 2010·Granted Mar 19, 2013·15 cites·15 claims
- 0483US9029374B2Chromenone derivativesASTRAZENECA AB·Filed 2014·Granted May 12, 2015·5 cites·8 claims
- 0577US12421208B2Chemical compoundsASTRAZENECA AB·Filed 2023·Granted Sep 23, 2025·0 cites·9 claims
- 0676US2025368615A1Chemical compoundsASTRAZENECA AB·Filed 2025·Application pending·0 cites
- 0775US8530470B2Chromenone derivativesBARLAAM BERNARD CHRISTOPHE·Filed 2012·Granted Sep 10, 2013·3 cites·17 claims
- 0860US2024150321A1Pyrazolylsulfonamide compounds and their use in therapyHOTSPOT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0960US2024150365A1Pyridinylsulfonamide compounds and their use in therapyHOTSPOT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1057US9718800B2Chromenone derivativesASTRAZENECA AB·Filed 2016·Granted Aug 1, 2017·0 cites·2 claims
- 1156US2025136592A1C-linked inhibitors of enl/af9 yeatsBRIDGE MEDICINES·Filed 2022·Application pending·0 cites
- 1252US2016060240A1Chromenone derivativesASTRAZENECA AB·Filed 2015·Application pending·0 cites
- 1350US2014038937A1Chromenone DerivativesASTRAZENECA AB·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sebastien Louis Degorce files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →